Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Allogeneic Stem Cell Transplantation in Angioimmunoblastic T-Cell Lymphoma (AITL): A Retrospective Survey from the Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation (EBMT).

Charalampia Kyriakou, MD, C. Canals, MD, G. Taghipour, J. Finke, MD, H. Kolb, MD, A. Goldstone, MD, A. Sureda, MD, N. Schmitz, MD

Blood (2007) 110 (11): 3042.

https://doi.org/10.1182/blood.V110.11.3042.3042

Published: 2007

Journal Articles

Allogeneic Stem Cell Transplantation (Allo-SCT) in the Management of Advanced Waldenstrom’s Macroglobulinemia (WM).

Charalampia Kyriakou, MD, C. Canals, MD, A. Sureda, MD, G. Taghipour, J. Cornelissen, MD, R. Willemze, MD, G. Socie, MD, H. Greinix, MD, J. Kienast, MD, R. Hamladji, MD, M. Kazmi, MD, P. Jacobs, MD, N. Schmitz, MD

Blood (2007) 110 (11): 619.

https://doi.org/10.1182/blood.V110.11.619.619

Published: 2007

Journal Articles

The Role of Autologous Stem Cell Transplantation (ASCT) in Patients with Advanced Waldenström’s Macroglobulinemia.

Charalampia Kyriakou, MD, C. Canals, MD, A. Sureda, MD, G. Taghipour, C. Gisselbrecht, MD, P. Mazza, MD, E. Montserrat, MD, N. Niederwieser, MD, K. Indrak, MD, A. Kolbe, MD, P. Biron, MD, A. Levis, MD, A. Goldstone, MD, N. Schmitz, MD

Blood (2007) 110 (11): 941.

https://doi.org/10.1182/blood.V110.11.941.941

Published: 2007

Journal Articles

HuMax-CD4 (Zanolimumab), a Fully Human Monoclonal Antibody: Early Results of an Ongoing Clinical Trial in CD4 + Peripheral T-Cell Lymphoma of Non-Cutaneous Type.

Francesco d’Amore, T. Relander, H. Hagberg, A. Osterborg, M. Hansen, L. Moeller, P. Johnson, J. Radford, B. Hancock, M. Gramatzki, S. Krause, M. Dreyling, N. Schmitz, S. Lisby, O. Baadsgaard

Blood (2005) 106 (11): 3354.

https://doi.org/10.1182/blood.V106.11.3354.3354

Published: 2005

Journal Articles

Efficacy of Rituximab Combined in Salvage- and High Dose-Therapy (HDT) for Patients with Relapsed NHL; Interim Analysis of a Multicenter Phase II Study.

G. Hess, MD, T. Flohr, MD, N. Frickhofen, MD, H. Wolf, MD, M. Gramatzki, MD, H. Link, MD, N. Peter, MD, N. Basara, MD, N. Schmitz, MD, A. Banat, MD, M. Kneba, MD, C. Huber, MD, G. Derigs, MD

Blood (2004) 104 (11): 1325.

https://doi.org/10.1182/blood.V104.11.1325.1325

Published: 2004

Journal Articles

Moderate Dose Escalation for Advanced Stage Hodgkin’s Disease Using the Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Scheme and Adjuvant Radiotherapy: A Study of the German Hodgkin’s Lymphoma Study Group

Blood (1998) 92 (12): 4560–4567.

https://doi.org/10.1182/blood.V92.12.4560

Published: 1998

Journal Articles

Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation

HH Euler, AM Marmont, A Bacigalupo, S Fastenrath, P Dreger, M Hoffknecht, AR Zander, B Schalke, U Hahn, R Haas, N Schmitz

Blood (1996) 88 (9): 3621–3625.

https://doi.org/10.1182/blood.V88.9.3621.bloodjournal8893621

Published: 1996

Journal Articles

Autologous progenitor cell transplantation: prior exposure to stem cell- toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts

P Dreger, M Kloss, B Petersen, T Haferlach, H Loffler, M Loeffler, N Schmitz

Blood (1995) 86 (10): 3970–3978.

https://doi.org/10.1182/blood.V86.10.3970.bloodjournal86103970

Published: 1995

Journal Articles

Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) [see comments]

N Schmitz, P Dreger, M Suttorp, EB Rohwedder, T Haferlach, H Loffler, A Hunter, NH Russell

Blood (1995) 85 (6): 1666–1672.

https://doi.org/10.1182/blood.V85.6.1666.bloodjournal8561666

Published: 1995

Journal Articles

Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation [letter]

P Dreger, M Suttorp, T Haferlach, H Loffler, N Schmitz, W Schroyens

Blood (1993) 81 (5): 1404–1407.

https://doi.org/10.1182/blood.V81.5.1404a.1404a

Published: 1993

Journal Articles

Fractionated total body irradiation and high-dose VP 16-213 followed by allogeneic bone marrow transplantation in advanced leukemias

N Schmitz, W Gassmann, M Rister, W Johannson, M Suttorp, F Brix, JJ Holthuis, W Heit, B Hertenstein, J Schaub

Blood (1988) 72 (5): 1567–1573.

https://doi.org/10.1182/blood.V72.5.1567.1567

Published: 1988

Journal Articles

Comparison of cyclophosphamide, cytarabine, and etoposide as immunosuppressive agents before allogeneic bone marrow transplantation

W Gassmann, L Uharek, HU Wottge, N Schmitz, H Loffler, W Mueller-Ruchholtz

Blood (1988) 72 (5): 1574–1579.

https://doi.org/10.1182/blood.V72.5.1574.1574

Published: 1988

Journal Articles

Recurrence of acute lymphoblastic leukemia in donor cells after allogeneic marrow transplantation associated with a deletion of the long arm of chromosome 6

N Schmitz, W Johannson, G Schmidt, K von der Helm, H Loffler

Blood (1987) 70 (4): 1099–1104.

https://doi.org/10.1182/blood.V70.4.1099.1099

Published: 1987

NARROW

Allogeneic Stem Cell Transplantation in Angioimmunoblastic T-Cell Lymphoma (AITL): A Retrospective Survey from the Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation (EBMT).

Allogeneic Stem Cell Transplantation (Allo-SCT) in the Management of Advanced Waldenstrom’s Macroglobulinemia (WM).

The Role of Autologous Stem Cell Transplantation (ASCT) in Patients with Advanced Waldenström’s Macroglobulinemia.

HuMax-CD4 (Zanolimumab), a Fully Human Monoclonal Antibody: Early Results of an Ongoing Clinical Trial in CD4 + Peripheral T-Cell Lymphoma of Non-Cutaneous Type.

Efficacy of Rituximab Combined in Salvage- and High Dose-Therapy (HDT) for Patients with Relapsed NHL; Interim Analysis of a Multicenter Phase II Study.

Moderate Dose Escalation for Advanced Stage Hodgkin’s Disease Using the Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Scheme and Adjuvant Radiotherapy: A Study of the German Hodgkin’s Lymphoma Study Group

Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation

Autologous progenitor cell transplantation: prior exposure to stem cell- toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts

Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) [see comments]

Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation [letter]

Fractionated total body irradiation and high-dose VP 16-213 followed by allogeneic bone marrow transplantation in advanced leukemias

Comparison of cyclophosphamide, cytarabine, and etoposide as immunosuppressive agents before allogeneic bone marrow transplantation

Recurrence of acute lymphoblastic leukemia in donor cells after allogeneic marrow transplantation associated with a deletion of the long arm of chromosome 6

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only